Boston Scientific To Pay J&J $1.7B In Stent Settlement
Boston Scientific Corp. has agreed to pay Johnson & Johnson Inc. $1.725 billion to resolve a handful of stent patent disputes between the companies, including two that had been set to...To view the full article, register now.
Already a subscriber? Click here to view full article